Transcriptomic Analyses of MYCN-Regulated Genes in Anaplastic Wilms' Tumour Cell Lines Reveals Oncogenic Pathways and Potential Therapeutic Vulnerabilities.

Szemes, Marianna; Melegh, Zsombor; Bellamy, Jacob; Park, Ji Hyun; Chen, Biyao; Greenhough, Alexander; Catchpoole, Daniel; Malik, Karim

Szemes, Marianna; Melegh, Zsombor; Bellamy, Jacob; Park, Ji Hyun; Chen, Biyao; Greenhough, Alexander; Catchpoole, Daniel; Malik, Karim.

Afiliação

Szemes M; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Melegh Z; Department of Cellular Pathology, Southmead Hospital, Bristol BS10 5NB, UK.
Bellamy J; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Park JH; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Chen B; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Greenhough A; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Catchpoole D; Department of Applied Sciences, University of the West of England, Bristol BS16 1QY, UK.
Malik K; The Kids Research Institute, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.

Cancers (Basel) ; 13(4)2021 Feb 06.

Article em En | MEDLINE | ID: mdl-33562123